Costa Karen Sarmento, Francisco Priscila Maria S Bergamo, Malta Débora Carvalho, Barros Marilisa Berti de Azevedo
Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, Brasil.
Secretaria de Vigilância em Saúde, Ministério da Saúde, Brasília, Brasil.
Cad Saude Publica. 2016 Feb;32(2):e00090014. doi: 10.1590/0102-311X00090014. Epub 2016 Feb 23.
This study aimed to analyze differences between patients with diabetes and hypertension in drug treatment and their sources for obtaining medication. This was a cross-sectional study with data from the VIGITEL telephone survey in 2011 in Brazil's state capitals and Federal District. Some 72% of the 15,027 hypertensive patients and 78.2% of the 4,083 diabetics were on medication; 45.8% of the hypertensive patients obtained their medications from public health units, 15.9% from the Popular Pharmacy program, and 38.3% from drugstores, pharmacies, and other sources. The rates among diabetics were 54.4%, 16.2%, and 29.4%, respectively. In the public health units the percentages were highest among individuals with less schooling, black or brown skin, and without private health plans, while the percentages in the Popular Pharmacy program and drugstores/pharmacies and other sources were higher among individuals with more schooling, white skin, and private health plans. Access to different sources of medicines showed disparities between Brazil's regions and state capitals and between social segments of the population.
本研究旨在分析糖尿病患者和高血压患者在药物治疗方面的差异以及他们获取药物的来源。这是一项横断面研究，数据来自2011年巴西各州首府和联邦区的VIGITEL电话调查。15027名高血压患者中约72%正在服药，4083名糖尿病患者中78.2%正在服药；45.8%的高血压患者从公共卫生机构获取药物，15.9%从大众药房计划获取，38.3%从药店、药房及其他来源获取。糖尿病患者的相应比例分别为54.4%、16.2%和29.4%。在公共卫生机构中，受教育程度较低、皮肤为黑色或棕色且没有私人健康保险的人群所占比例最高，而在大众药房计划以及药店/药房和其他来源中，受教育程度较高、皮肤为白色且有私人健康保险的人群所占比例更高。获取不同药物来源的情况在巴西各地区和州首府之间以及不同社会阶层的人群之间存在差异。
